ACME UNITED CORP - 10-Q Summary (Q3 2025)
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Acme United Corporation manufactures and distributes first aid, medical, cutting, and sharpening products. The company operates in three reportable segments: United States, Canada, and Europe. The registrant is classified as an accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Net Sales | $49.06 million | $48.17 million | $149.02 million | $148.55 million |
| Gross Profit | $19.20 million (39.1%) | $18.56 million (38.5%) | $59.26 million (39.8%) | $58.59 million (39.4%) |
| Operating Income | $3.01 million | $2.93 million | $11.82 million | $11.86 million |
| Net Income | $1.90 million | $2.23 million | $8.31 million | $8.32 million |
| Diluted EPS | $0.46 | $0.54 | $2.03 | $2.03 |
| Cash from Operations (YTD) | $10.08 million (vs. $5.60 million YTD 2024) | |||
| Ending Cash Balance | $5.15 million (Sep 30, 2025) | |||
| Total Debt | ~$28.36 million (Long-term debt + Current portion of mortgage) | |||
| Working Capital | $76.62 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 2% in Q3 and remained flat YTD compared to 2024. Growth was driven by First Aid and Medical products, particularly in Canada (+5% Q3, +14% YTD) and Europe (+13% Q3). U.S. sales were flat Q3 and down 1% YTD due to order cancellations from tariff uncertainty.
- Profitability: Gross margin improved slightly to 39.1% in Q3 (from 38.5%) and 39.8% YTD (from 39.4%). Operating income was relatively flat year-over-year.
- Interest Expense: Net interest expense decreased significantly ($422k in Q3 vs. $535k prior year) due to lower average borrowings and interest rates.
- Tax Rate: The effective tax rate for Q3 2025 was 22%, compared to 8% in Q3 2024. The prior year's lower rate was due to a large excess tax benefit from stock option exercises.
- Capital Expenditures: YTD 2025 CapEx was $9.75 million, significantly higher than the $5.45 million in YTD 2024. This includes a $6.0 million purchase of a new manufacturing facility in Mt. Pleasant, TN, in July 2025.
Guidance, Outlook, Risks, and Unusual Items
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2025, due to a material weakness in IT general controls (logical security and privileged access). Remediation is expected to be completed by December 31, 2025.
- Debt Facility: In June 2025, the company extended its $65 million revolving credit facility maturity to May 31, 2027. Outstanding borrowings were $18.27 million as of September 30, 2025.
- Risk Factors: Significant risks include global trade policies and tariffs (specifically on Chinese goods), inflationary costs, supply chain disruptions, and geopolitical tensions. The company notes that tariff uncertainty has already led to customer order cancellations in the U.S. segment.
- Acquisition: The company acquired Elite First Aid in May 2024. A contingent payment of $500,000 remains outstanding, dependent on revenue milestones through December 31, 2025.
Investor Verification Checklist
- Remediation of Material Weakness: Verify the timeline and effectiveness of the IT general controls remediation plan to ensure future financial reporting reliability.
- Tariff Impact: Monitor the U.S. segment for continued order cancellations or margin compression due to trade policy changes and tariffs on Chinese imports.
- Inventory Levels: Review inventory turnover (2.0x) and the $60.2 million inventory balance to ensure no obsolescence risks, especially given the new facility expansion.
- Cash Flow Sustainability: Confirm that operating cash flow ($10.1M YTD) remains sufficient to cover the increased CapEx ($9.8M YTD) and dividend payments without excessive reliance on the credit facility.
- Contingent Liabilities: Track the performance of the Elite First Aid acquisition against the $500,000 revenue milestone for the contingent payment.